###begin article-title 0
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
The M/GP5 Glycoprotein Complex of Porcine Reproductive and Respiratory Syndrome Virus Binds the Sialoadhesin Receptor in a Sialic Acid-Dependent Manner
###end article-title 0
###begin p 1
Conceived and designed the experiments: WVB PRC PLD HJN. Performed the experiments: WVB HVG JQZ PLD. Analyzed the data: WVB JQZ PRC PLD HJN. Wrote the paper: WVB PLD.
###end p 1
###begin p 2
paragraph sign These authors share senior authorship.
###end p 2
###begin p 3
###xml 973 974 973 974 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 978 979 978 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 986 987 986 987 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1025 1026 1025 1026 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1237 1238 1237 1238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 4 55 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 57 62 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 85 90 <span type="species:ncbi:9823">swine</span>
###xml 168 173 <span type="species:ncbi:9823">swine</span>
###xml 599 604 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 746 751 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 807 812 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 899 904 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1051 1056 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1304 1309 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1431 1436 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
The porcine reproductive and respiratory syndrome virus (PRRSV) is a major threat to swine health worldwide and is considered the most significant viral disease in the swine industry today. In past years, studies on the entry of the virus into its host cell have led to the identification of a number of essential virus receptors and entry mediators. However, viral counterparts for these molecules have remained elusive and this has made rational development of new generation vaccines impossible. The main objective of this study was to identify the viral counterparts for sialoadhesin, a crucial PRRSV receptor on macrophages. For this purpose, a soluble form of sialoadhesin was constructed and validated. The soluble sialoadhesin could bind PRRSV in a sialic acid-dependent manner and could neutralize PRRSV infection of macrophages, thereby confirming the role of sialoadhesin as an essential PRRSV receptor on macrophages. Although sialic acids are present on the GP3, GP4 and GP5 envelope glycoproteins, only the M/GP5 glycoprotein complex of PRRSV was identified as a ligand for sialoadhesin. The interaction was found to be dependent on the sialic acid binding capacity of sialoadhesin and on the presence of sialic acids on GP5. These findings not only contribute to a better understanding of PRRSV biology, but the knowledge and tools generated in this study also hold the key to the development of a new generation of PRRSV vaccines.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 783 784 783 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 984 985 984 985 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1274 1275 1274 1275 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 4 55 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 57 62 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 85 90 <span type="species:ncbi:9823">swine</span>
###xml 503 508 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 641 646 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 809 814 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1078 1083 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1168 1173 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
The porcine reproductive and respiratory syndrome virus (PRRSV) is a major threat to swine health worldwide. The virus specifically targets subpopulations of macrophages, central players in the immune system, and can persist in animals for extended periods of time due to a hampered immunity. At present, no vaccines are available that are both safe and effective and it is clear that a more rational vaccine design is needed to solve this problem. Therefore, advancing our fundamental understanding of PRRSV biology is crucial. The macrophage-specific lectin sialoadhesin is a crucial viral receptor on macrophages and although its role in PRRSV infection is well documented, its viral counterparts have remained unknown. Using a soluble form of sialoadhesin, we identified the M/GP5 glycoprotein complex of PRRSV as the ligand for sialoadhesin and found this ligand-receptor interaction to be critically dependent on the lectin activity of sialoadhesin and on sialic acids on the GP5 glycoprotein. These data represent a major breakthrough in the understanding of the role of PRRSV proteins in viral entry and pave the way for the development of a new generation of PRRSV vaccines capable of inducing an immunity that specifically blocks the interaction between viral M/GP5 and sialoadhesin.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 102 105 102 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Collins1">[1]</xref>
###xml 106 109 106 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wensvoort1">[2]</xref>
###xml 416 427 416 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nidovirales</italic>
###xml 436 449 436 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arteriviridae</italic>
###xml 496 499 496 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Cavanagh1">[3]</xref>
###xml 653 659 653 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 816 819 816 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Neumann1">[4]</xref>
###xml 963 966 963 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Li1">[5]</xref>
###xml 967 970 967 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Zhou1">[7]</xref>
###xml 64 67 <span type="species:ncbi:9823">pig</span>
###xml 125 130 <span type="species:ncbi:9823">swine</span>
###xml 489 494 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 539 544 <span type="species:ncbi:9823">swine</span>
###xml 618 623 <span type="species:ncbi:9823">swine</span>
###xml 701 706 <span type="species:ncbi:9823">swine</span>
###xml 1061 1066 <span type="species:ncbi:9823">swine</span>
At the end of the 1980s, a new syndrome was described affecting pig herds in North America and Canada [1],[2]. This 'mystery swine disease' manifested itself in respiratory problems and reproductive disorders and was eventually designated Porcine Reproductive and Respiratory Syndrome (PRRS), reflecting the associated disease symptoms. The causative agent is a positive sense RNA virus that groups within the order Nidovirales, family Arteriviridae, and is referred to as the PRRS virus (PRRSV) [3]. At present, the disease is endemic in swine-producing countries worldwide, causing enormous production losses in the swine industry. A study by Neumann et al. assessing the economic impact of PRRS on swine production in the US reported an annual loss of approximately 560.32 million US dollars due to this syndrome [4]. Also, recent studies report on the emergence of highly pathogenic variants of the virus in Asia causing atypical PRRS or 'High Fever' disease [5]-[7]. Consequently, PRRS is considered to be the most significant viral disease problem in the swine industry today.
###end p 7
###begin p 8
###xml 234 237 234 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Botner1">[8]</xref>
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Scortti1">[10]</xref>
###xml 256 260 256 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Labarque1">[11]</xref>
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Zuckermann1">[15]</xref>
###xml 61 66 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 110 115 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 343 348 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 463 468 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 576 581 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 654 659 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Availability of safe and effective vaccines is essential for PRRSV control. Currently, there are two types of PRRSV vaccines on the market: attenuated and inactivated vaccines. However, these have specific drawbacks concerning safety [8]-[10] and efficacy [11]-[15] and there is a strong demand for a new generation of vaccines. Up until now, PRRSV vaccine development often has followed the trial and error approach. As there was a clear gap in the knowledge of PRRSV ligands that bind to specific receptors, it was difficult to aim for specific blocking of crucial steps in PRRSV infection of the porcine macrophage. A fundamental understanding of how PRRSV enters its host cell is crucial to reverse the tide.
###end p 8
###begin p 9
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Benfield1">[16]</xref>
###xml 232 236 232 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Snijder1">[21]</xref>
###xml 376 377 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 386 387 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 394 395 394 395 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Snijder1">[21]</xref>
###xml 474 475 474 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 568 572 568 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Snijder1">[21]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Gonin1">[24]</xref>
###xml 617 618 617 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Snijder1">[21]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Mardassi2">[25]</xref>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Verheije1">[26]</xref>
###xml 721 722 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 726 727 726 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 734 735 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Snijder1">[21]</xref>
###xml 891 895 891 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wissink1">[23]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Meulenberg2">[27]</xref>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wu1">[29]</xref>
###xml 4 9 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 430 435 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
The PRRSV virion consists of a nucleocapsid that is surrounded by a lipid envelope. The capsid structure consists of nucleocapsid proteins (N) and contains the viral genome: a single, positive RNA strand of approximately 15 kb [16]-[21]. In the viral envelope, six structural proteins are embedded: the small envelope protein E, the membrane protein M and the glycoproteins GP2, GP3, GP4 and GP5[21]. However, some North American PRRSV isolates do not seem to incorporate GP3 as a structural membrane protein, in contrast to European and other North American isolates [21]-[24]. The major structural proteins M and GP5 have been shown to form disulfide-linked heterodimers [21],[25],[26]. The minor structural proteins GP2, GP3 and GP4 form non-covalent heterotrimers in the virion and there are indications that also the E protein may be associated with the minor glycoprotein trimer [21], [23], [27]-[29].
###end p 9
###begin p 10
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Duan1">[30]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Teifke1">[31]</xref>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 361 369 361 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Kim1">[32]</xref>
###xml 43 48 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 442 462 <span type="species:ncbi:9534">African green monkey</span>
As has been shown for other arteriviruses, PRRSV shows a marked in vivo tropism for cells of the monocyte/macrophage lineage: the virus infects specific subsets of porcine macrophages [30],[31]. Primary cultures of alveolar macrophages (PAM) are the only cells that allow efficient ex vivo virus propagation. In addition, a limited number of cell lines support in vitro virus replication upon adaptation of the virus. One such cell line, the African green monkey kidney cell line MARC-145 [32], has become the most widely used cell type for PRRS virus production.
###end p 10
###begin p 11
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte1">[33]</xref>
###xml 375 379 375 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Vanderheijden1">[35]</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Vanderheijden2">[36]</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Nauwynck1">[37]</xref>
###xml 888 892 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte3">[38]</xref>
###xml 951 955 951 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte4">[39]</xref>
###xml 977 983 977 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1206 1210 1198 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte4">[39]</xref>
###xml 1671 1675 1663 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-VanGorp1">[40]</xref>
###xml 1676 1680 1668 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Calvert1">[41]</xref>
###xml 1724 1728 1716 1720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Nauwynck1">[37]</xref>
###xml 1729 1733 1721 1725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Kreutz1">[42]</xref>
###xml 1829 1833 1821 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Misinzo1">[43]</xref>
###xml 67 72 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 191 196 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 494 499 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1236 1241 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1269 1274 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Over the past years, various studies have focussed on the entry of PRRSV into its host cell. These efforts have resulted in the identification of a number of macrophage molecules involved in PRRSV entry. As for many other viruses, initial binding of the virus to its host cell occurs via interactions with heparan sulphate glycosaminoglycans present on the cell surface [33]-[35]. The virus receptor that determines subsequent virus entry and that likely accounts for the macrophage tropism of PRRSV has been identified as porcine sialoadhesin (pSn). This macrophage-specific molecule is a sialic acid-binding immunoglobulin-like lectin (siglec) that mediates virus attachment and subsequent internalization via clathrin-mediated endocytosis [36],[37]. Virus attachment to this receptor is dependent on the sialic acid-binding activity of the N-terminal immunoglobulin-like domain of pSn [38] and on the presence of sialic acids on the virion surface [39]. A study by Delputte et al. pointed out that alpha2-3 linked sialic acids and to a lesser extent alpha2-6 linked sialic acids, most likely present on complex N-linked glycans attached to viral envelope glycoproteins, are involved in this interaction [39]. Clearly, a glycosylated PRRSV protein is responsible for PRRSV binding to pSn, but the exact viral ligand has not yet been identified. After pSn-dependent internalization into the endosomal compartment of the macrophage, the viral genome is released into the cytoplasm, thereby initiating the transcriptional and translational events necessary for the production of new virions. The scavenger receptor CD163 has been shown to be essential for virus uncoating [40],[41]. A pH drop within the endosome is required [37],[42] and also the aspartic protease cathepsin E and a yet unidentified trypsin-like serine protease [43] have been implicated in this process.
###end p 11
###begin p 12
###xml 653 654 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 749 750 749 750 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 64 69 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Although pSn has been shown to be a critical entry receptor for PRRSV on macrophages, viral envelope glycoproteins that act as ligands for this receptor have remained elusive. In the light of vaccine development, knowledge on this is particularly interesting, since it allows targeting of the immune response to a specific, critical step in virus infection. Vaccination with a functional viral pSn-binding epitope can elicit a protective immune response that specifically blocks the crucial, pSn-dependent internalization of the virus into its host cell. By construction and use of soluble recombinant porcine sialoadhesins, we identified the viral M/GP5 glycoprotein complex as a ligand for pSn and showed the sialic acid-dependency of the pSn-M/GP5 interaction.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
Ethics statement
###end title 14
###begin p 15
###xml 222 227 <span type="species:ncbi:9606">human</span>
The experimental procedure for the collection of porcine alveolar macrophages was authorized and supervised by the Ethical and Animal Welfare Committee of the Faculty of Veterinary Medicine of Ghent University. The use of human red blood cells was approved by the Medical Ethical Committee of the Ghent University Hospital and informed written consent was obtained from the donors of red blood cells.
###end p 15
###begin title 16
Monoclonal antibodies
###end title 16
###begin p 17
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Vanderheijden2">[36]</xref>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Duan2">[44]</xref>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Costers1">[45]</xref>
###xml 377 378 377 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 382 383 382 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 472 476 472 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-vanNieuwstadt1">[28]</xref>
###xml 498 502 498 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-WieczorekKrohmer1">[46]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Nauwynck2">[47]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Lefebvre1">[48]</xref>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
###xml 210 215 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Detection of pSn was performed using the mouse monoclonal antibody (mAb) 41D3 [36],[44] that recognizes a conformational epitope within the N-terminal sialic acid-binding domain of pSn. Detection of structural PRRSV proteins was performed using the following mAbs: mAb VII2D/5-1D (IgG1), mAb XVI11C/5-10F (IgG2a) and mAb VII2H/2-4D (IgG1) [45] were used for the detection of GP3, GP4 and GP5, respectively. Detection of the M protein was performed using mAb 126.3 (IgG2a) [28] and mAb P3/27 (IgG1) [46] was used for detection of the N protein. MAb 13D12 [47] and mAb 16G12 [48] were used as isotype-matched, irrelevant control mAbs for the mAbs with IgG1 and IgG2a isotype, respectively.
###end p 17
###begin title 18
Cells and viruses
###end title 18
###begin p 19
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wensvoort1">[2]</xref>
###xml 209 215 209 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-VanGorp1">[40]</xref>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-VanGorp1">[40]</xref>
###xml 479 480 479 480 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 101 105 <span type="species:ncbi:9823">pigs</span>
###xml 113 118 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Porcine alveolar macrophages (PAM) were obtained from 4- to 6-week-old conventional Belgian Landrace pigs from a PRRSV-negative herd as described by Wensvoort et al.[2] and cultivated as described by Van Gorp et al.[40]. MARC-145 cells were cultivated as described before [40]. HEK-293T cells were grown in DMEM (Gibco) containing 10% heat-inactivated FBS (Gibco), 2 mM L-glutamine, 1 mM sodium pyruvate and a mixture of antibiotics. Cell cultures were kept in a humidified 5% CO2 atmosphere at 37degreesC.
###end p 19
###begin p 20
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human red blood cells (RBCs) were obtained from healthy donors and stored at 4degreesC in Alsever's solution for up to 7 days.
###end p 20
###begin p 21
###xml 51 54 51 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wensvoort1">[2]</xref>
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte4">[39]</xref>
###xml 477 483 477 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-VanGorp1">[40]</xref>
###xml 23 44 <span type="species:ncbi:11049">PRRSV strain Lelystad</span>
The European prototype PRRSV strain Lelystad Virus [2] (LV; kindly provided by G. Wensvoort) was passaged 14 times on macrophages (macrophage-grown LV stock) or 13 times on macrophages and subsequently 5 times on MARC-145 cells (MARC-145-grown LV stock). Virus was semipurified from the supernatants via ultracentrifugation as described before [39]. Virus titrations on MARC-145 cells and macrophages and calculation of the virus titers were performed as described by Van Gorp et al.[40].
###end p 21
###begin title 22
Construction, production and purification of pSn-Fc fusion proteins
###end title 22
###begin p 23
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Vanderheijden2">[36]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Hartnell1">[49]</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Zhang1">[50]</xref>
###xml 443 469 443 469 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CCTTCACCATGGACTTCCTG-3&#8242;</named-content>
###xml 489 534 489 534 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-ACTAGATCTACTTACCTGTGCTGACCACCACGCTGACAG-3&#8242;</named-content>
###xml 855 858 855 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">116</sup>
###xml 1016 1061 1016 1061 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCGGGCTCCTATAACTTCgaaTTTGAGATCAGCGAGGGC-3&#8242;</named-content>
###xml 1081 1126 1081 1126 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-GCCCTCGCTGATCTCAAAttcGAAGTTATAGGAGCCCGA-3&#8242;</named-content>
###xml 1152 1154 1152 1154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 205 210 <span type="species:ncbi:9606">human</span>
The pSn cDNA had been cloned previously into the pcDNA3.1/D vector (Invitrogen) [36]. The soluble Fc-tagged pSn, pSn4D-Fc, was generated by polymerase chain reaction (PCR) amplification as done before for human sialoadhesin [49] and cloning into a modified version of the pEE14 vector, designated pEE14-3C-Fc [50]. The cDNA fragment corresponding to the first 4 N-terminal immunoglobulin-like domains of pSn was amplified using forward primer 5'-CCTTCACCATGGACTTCCTG-3' and reverse primer 5'-ACTAGATCTACTTACCTGTGCTGACCACCACGCTGACAG-3'. The pEE14-3C-Fc vector was cut with HindIII, treated with Klenow DNA polymerase to obtain blunt ends and subsequently cut with BamHI. The PCR product was digested with BglII and cloned into the cut pEE14-3C-Fc vector, yielding pEE14-pSn4D-3C-Fc. To obtain a non-sialic acid-binding pSn4D-Fc protein, a point-mutation (R116E) was introduced in the sialic acid-binding domain in pEE14-pSn4D-3C-Fc using the Quickchange site directed mutagenesis kit (Stratagene) with forward primer 5'-TCGGGCTCCTATAACTTCgaaTTTGAGATCAGCGAGGGC-3' and reverse primer 5'-GCCCTCGCTGATCTCAAAttcGAAGTTATAGGAGCCCGA-3', resulting in pEE14-pSn4DRE-3C-Fc.
###end p 23
###begin p 24
###xml 352 353 352 353 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
For production of the pSn-Fc chimeras, HEK-293T cells were transiently transfected using calcium phosphate. Transfected cells were cultured for 3 days in DMEM supplemented with 3% IgG-depleted low IgG FBS (Gibco), 2 mM L-glutamine, 1 mM sodium pyruvate, 1% nonessential amino acids (100x stock; Gibco) and a mixture of antibiotics in a humidified 5% CO2 atmosphere at 37degreesC, after which the culture supernatant was collected. The pSn-Fc fusion proteins were purified from the supernatant using standard protein A sepharose chromatography following the manufacturer's instructions (GE Healthcare). Fractions of the eluate containing the purified protein were pooled and the buffer was exchanged to phosphate-buffered saline (PBS) by dialysis. Purified protein was stored at -70degreesC until use.
###end p 24
###begin title 25
Solid phase red blood cell binding assay
###end title 25
###begin p 26
###xml 1316 1320 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Zhang2">[51]</xref>
###xml 1570 1585 1552 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vibrio cholerae</italic>
###xml 135 139 <span type="species:ncbi:9925">goat</span>
###xml 145 150 <span type="species:ncbi:9606">human</span>
###xml 306 312 <span type="species:ncbi:9913">bovine</span>
###xml 1570 1585 <span type="species:ncbi:666">Vibrio cholerae</span>
Each well of an Immulon 4HBX 96-well flat-bottomed microtiter plate (Dynax Technologies Inc.) was coated with 50 microl of 8 microg/ml goat anti-human IgG (Fc- specific; Sigma-Aldrich Corp.) in 0.05 M carbonate-bicarbonate buffer (pH 9.6; Sigma-Aldrich Corp.). Plates were washed with PBS containing 0.25% bovine serum albumin (PBA), after which 2-fold dilution series of the purified siglec-Fc chimera were added to the wells and incubated for 2 h at ambient temperature. Unbound siglec-Fc protein was removed by washing with PBA. RBCs were washed twice in PBA and resuspended in PBA at 0.25% (v/v) immediately before use. 100 microl of the RBC suspension was added to each well and the plate was incubated for 30 min at 37degreesC. The wells were gently washed with PBA to remove unbound RBCs and RBC binding was evaluated using an Olympus CK40-F200 inverted light microscope (Opelco). To quantify RBC binding, the plate was dried, fixed with methanol and dried again, after which a peroxidase substrate assay was performed (Substrate Reagent Pack; R&D Systems; processed according to manufacturer's instructions). The result was evaluated measuring the optical density at 450 nm (OD450) using a Multiskan RC (Thermo Labsystems). As a positive control, an identical assay was performed in parallel for mSiglecE-Fc [51], a protein with established sialic acid-binding activity. As a control for sialic acid-dependent binding, sialidase-treated RBCs were used. To remove sialic acids from the cell surface, RBCs were diluted (0.25% v/v) in RPMI-1640 containing 50 mU/ml Vibrio cholerae sialidase (Roche Applied Science; specific for alpha2-3, 6, 8 linked sialic acids) and incubated for 1 h at 37degreesC. The RBCs were subsequently washed with PBA to remove the enzyme, resuspended in PBA at 0.25% (v/v) and used in the solid phase binding assay as described.
###end p 26
###begin title 27
SDS-PAGE, Coomassie Blue staining and Western Blot analysis of pSn-Fc proteins
###end title 27
###begin p 28
###xml 859 863 <span type="species:ncbi:9925">goat</span>
###xml 869 874 <span type="species:ncbi:10090">mouse</span>
###xml 1043 1047 <span type="species:ncbi:9925">goat</span>
###xml 1053 1058 <span type="species:ncbi:9606">human</span>
Samples of purified pSn-Fc protein were mixed with (non-) reducing Laemmli buffer, boiled for 5 min and subjected to SDS-PAGE (8% gel) using a BioRad Mini Protean 3 system. For Coomassie Blue staining, the SDS-PAGE gel was incubated successively in Coomassie Blue staining solution (0.125% Coomassie Blue, 50% methanol, 10% acetic acid), destaining solution I (50% methanol, 10% acetic acid) and destaining solution II (5% methanol, 7% acetic acid). Alternatively, for Western Blot analysis, proteins were transferred from the SDS-PAGE gel to a PVDF membrane (Membrane Hybond-P, GE Healthcare) via Western Blotting (BioRad Mini Trans Blot). The membrane was blocked overnight in PBS +0.1% Tween 20+5% skimmed milk. Detection of pSn-Fc protein was performed by subsequent incubation of the blot with the pSn-specific mAb 41D3 and peroxidase-labeled polyclonal goat anti-mouse antibodies (Dako), followed by visualization using enhanced chemiluminiscence (ECL; GE Healthcare). Alternatively, pSn-Fc protein was detected using peroxidase-labeled goat anti-human IgG antibodies (Fc-specific; Sigma-Aldrich Corp.) and subsequent ECL.
###end p 28
###begin title 29
Analysis of intracellular processing of pSn-Fc proteins
###end title 29
###begin p 30
###xml 38 40 38 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 266 281 266 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vibrio cholerae</italic>
###xml 266 281 <span type="species:ncbi:666">Vibrio cholerae</span>
###xml 527 531 <span type="species:ncbi:9925">goat</span>
###xml 537 542 <span type="species:ncbi:9606">human</span>
Samples of purified pSn4D-Fc and pSn4DRE-Fc protein were either left untreated or were treated with endoglycosidase H or PNGase F (New England Biolabs Inc.; used according to manufacturer's instructions). Also, samples of both proteins were incubated with 100 mU/ml Vibrio cholerae sialidase (Roche Applied Science; used according to manufacturer's instructions) for 3 h at 37degreesC. After addition of reducing Laemmli buffer, samples were boiled for 5 min and analyzed via SDS-PAGE and Western Blot using peroxidase-labeled goat anti-human IgG antibodies as described above.
###end p 30
###begin title 31
###xml 18 23 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Evaluation of the PRRSV-binding capacity of pSn4D-Fc via precipitation experiments
###end title 31
###begin p 32
###xml 713 714 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1222 1224 1208 1210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 142 147 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 819 823 <span type="species:ncbi:9925">goat</span>
###xml 829 834 <span type="species:ncbi:10090">mouse</span>
100 microl of Dynabeads protein A (Invitrogen) were coated with 25 microg of pSn4D-Fc protein and incubated with semipurified, MARC-145-grown PRRSV LV at 37degreesC. After 90 min of incubation, the unbound virus fraction was collected, beads were washed 4 times with PBS and bound material was eluted with 0.1 M citrate buffer (pH 3.1). Samples of the semipurified virus, the bound and the unbound fraction were mixed with non-reducing Laemmli buffer, boiled for 5 min and resolved on a 12% SDS-PAGE gel. Subsequently, resolved proteins were transferred to a PVDF membrane via Western Blotting. The membrane was blocked overnight in PBS +0.1% Tween 20+5% skimmed milk and probed with a nucleocapsid-specific, a GP5-specific or an isotype-matched irrelevant control mAb in combination with peroxidase-labeled polyclonal goat anti-mouse antibodies. The detected protein bands were visualized using ECL. To confirm that the beads were efficiently coated with pSn-Fc protein, a sample of the bound fraction was subjected to SDS-PAGE and Western Blot analysis using the pSn-specific mAb 41D3. As a control, identical experiments were performed using uncoated beads and beads coated with the non-sialic acid-binding mutant pSn4DRE-Fc.
###end p 32
###begin title 33
###xml 18 23 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Evaluation of the PRRSV-binding capacity of pSn4D-Fc via infection-inhibition experiments
###end title 33
###begin p 34
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 159 161 155 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 264 265 252 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 270 272 258 260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">50</sub>
###xml 686 689 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wensvoort1">[2]</xref>
PAM were seeded at a concentration of 105 cells/well in 96-well plates and kept in culture for 48 h. 50 microl of a 3-fold dilution series of pSn4D-Fc or pSn4DRE-Fc (starting concentration 50 microg/ml) was mixed with a constant amount of virus (5 microl of a 2x105 TCID50/ml virus suspension) and incubated for 1 h at 37degreesC to allow binding. The mixtures were transferred to the PAM and cells were incubated for 1 h at 37degreesC. Soluble receptor-virus mixtures were then removed, fresh medium was added and cells were further incubated for 9 h at 37degreesC, after which they were fixed. Infected cells were then visualized via a nucleocapsid-specific immunoperoxidase staining [2] and counted.
###end p 34
###begin title 35
###xml 30 35 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Identification of pSn-binding PRRSV proteins and characterization of pSn-ligand interaction using pSn4D-Fc
###end title 35
###begin p 36
###xml 1013 1015 1013 1015 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 1155 1170 1155 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vibrio cholerae</italic>
###xml 65 70 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 618 623 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 721 725 <span type="species:ncbi:9925">goat</span>
###xml 731 736 <span type="species:ncbi:10090">mouse</span>
###xml 1155 1170 <span type="species:ncbi:666">Vibrio cholerae</span>
Viral proteins were solubilized from semipurified MARC-145-grown PRRSV LV by a 1 h incubation in TNE buffer (50 mM Tris-HCl (pH 7.4), 200 mM NaCl, 1 mM EDTA) containing 1% NP-40 (Roche Applied Science) and insoluble material was pelleted by centrifugation at 10,000xg for 45 min. Subsequently, the virus lysate was incubated with pSn4D-Fc-coated beads. The precipitation experiment, sample preparation and subsequent SDS-PAGE and Western Blotting were performed as described above. Membranes were blocked overnight in PBS +0.1% Tween 20+5% skimmed milk and probed with mAbs directed against the structural proteins of PRRSV LV and isotype-matched irrelevant control mAbs in combination with peroxidase-labeled polyclonal goat anti-mouse antibodies. Detected protein bands were visualized using ECL. Coating of the beads with pSn-Fc protein was checked as described above. To assess the sialic acid-dependency of the interaction, an identical experiment was performed using the non-sialic acid-binding mutant pSn4DRE-Fc. Alternatively, sialidase-treated virus was used in the precipitations. Semi-purified virus was incubated with 100 mU/ml sialidase from Vibrio cholerae in RPMI-1640 for 3 h at 37degreesC. In parallel, virus was incubated with the buffer in which the sialidase was supplied. Titration on alveolar macrophages revealed a 90% decrease in infectivity of sialidase-treated virus when compared to control-treated virus, indicating that sialidase treatment removed sialic acids implicated in viral entry. To evaluate the effect of the treatment on different envelope glycoproteins, samples of sialidase- and control-treated virus were subjected to SDS-PAGE and Western Blot analysis using specific mAbs. The remaining virus was lysed and subjected to immunoprecipitation using pSn4D-Fc as described above.
###end p 36
###begin p 37
###xml 159 161 159 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
Similar precipitation reactions were performed using macrophage-grown virus. Lysates of semipurified macrophage-grown virus were applied to pSn4D-Fc- and pSn4DRE-Fc-coated beads. The bound and unbound fractions as well as the original virus lysates were analyzed via SDS-PAGE and Western Blotting as described above.
###end p 37
###begin title 38
Accession numbers
###end title 38
###begin p 39
GenBank accession numbers ():
###end p 39
###begin p 40
###xml 0 5 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 6 20 <span type="species:ncbi:11049">Lelystad virus</span>
PRRSV Lelystad virus, complete genome (coding sequence): M96262
###end p 40
###begin p 41
###xml 0 5 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 6 20 <span type="species:ncbi:11049">Lelystad virus</span>
PRRSV Lelystad virus, individual structural proteins (protein): AAA46275 (GP2); AAA46276 (GP3); AAA46277 (GP4); AAA46278 (GP5); AAA46279 (M); AAA46280 (N); P0C6Y6 (E)
###end p 41
###begin p 42
Porcine sialoadhesin: AF509585 (mRNA, complete cds), AAP47136 (protein)
###end p 42
###begin p 43
Porcine CD163: EU016226 (mRNA, complete cds), ABV80230 (protein)
###end p 43
###begin p 44
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine siglec E: AY371487 (mRNA, complete cds), AAQ72479 (protein)
###end p 44
###begin title 45
Results
###end title 45
###begin title 46
Construction and structural characterization of pSn-Fc chimeras
###end title 46
###begin p 47
###xml 414 418 414 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte3">[38]</xref>
###xml 489 491 489 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 578 581 578 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">116</sup>
###xml 700 711 700 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000730.s001">Protocol S1</xref>
###xml 750 761 750 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="ppat.1000730.s002">Protocol S2</xref>
###xml 16 21 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 240 245 <span type="species:ncbi:9606">human</span>
###xml 271 276 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 400 405 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
To identify the PRRSV envelope glycoproteins interacting with pSn, we constructed a soluble form of the pSn receptor (pSn4D-Fc). This recombinant protein consists of the 4 N-terminal domains of pSn, coupled with the Fc- and hinge region of human IgG1 and allows study of PRRSV-pSn interactions in a cell-free context. The sialic acid-binding activity of pSn has been shown before to be essential for PRRSV binding [38]. Therefore, a non-sialic acid-binding mutant of the soluble pSn (pSn4DRE-Fc) was generated as a control. This protein was obtained by changing the amino acid R116, which is essential for sialic acid binding, to an E residue. PSn- and Fc-specific immunofluorescence cell stainings (Protocol S1) and ELISAs of the cell supernatants (Protocol S2) revealed that the pSn-Fc chimeras were expressed in transfected HEK-293T cells and that they were secreted into the culture medium (data not shown).
###end p 47
###begin p 48
###xml 289 296 289 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g001">Fig. 1A</xref>
###xml 405 407 405 407 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
After optimization of production and purification, all further tests and experiments were performed using purified pSn-Fc proteins. To check the purity of the proteins, samples were resolved on SDS-PAGE under reducing and non-reducing conditions and Coomassie Blue staining was performed (Fig. 1A). Under non-reducing conditions, a single band of more than 250 kDa was seen for both the pSn4D-Fc and pSn4DRE-Fc protein. Presence of a reducing agent resulted in single bands at about 80 kDa. These results indicate that the purified pSn-Fc proteins are present as disulfide-linked dimers under non-reducing conditions. The fact that single bands were obtained under each condition shows that the bulk of the protein in the purified fractions was pSn-Fc protein.
###end p 48
###begin title 49
Structural characterization of pSn-Fc proteins.
###end title 49
###begin p 50
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 42 44 42 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 163 164 163 164 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 246 248 246 248 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 318 319 318 319 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 339 341 339 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
(A) Samples of purified pSn4D-Fc and pSn4DRE-Fc proteins were subjected to non-reducing and reducing SDS-PAGE, after which Coomassie Blue staining was performed. (B) (Non-)reducing SDS-PAGE and Western Blot analysis of purified pSn4D-Fc and pSn4DRE-Fc proteins using Fc-specific antibodies and pSn-specific mAb 41D3. (C) pSn4D-Fc and pSn4DRE-Fc proteins were treated with specific glycosidases or control treated and subjected to reducing SDS-PAGE and Western Blot analysis using Fc-specific antibodies.
###end p 50
###begin p 51
###xml 77 84 77 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g001">Fig. 1B</xref>
###xml 141 143 141 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 401 403 401 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 511 516 <span type="species:ncbi:9606">human</span>
Purified proteins were also subjected to SDS-PAGE and Western Blot analysis (Fig. 1B). Under non-reducing conditions, both pSn4D-Fc and pSn4DRE-Fc were recognized by pSn-specific mAb 41D3. When SDS-PAGE was performed in the presence of a reducing agent, binding of mAb 41D3 to the blotted proteins was lost, which is in line with earlier observations for wild type pSn. Both the pSn4D-Fc and the pSn4DRE-Fc proteins could be detected on the blot membrane using polyclonal antibodies specific for the Fc-part of human IgG. Using the Fc-specific polyclonal antibodies for detection, additional bands could be observed with varying intensity in between batches. These bands most likely represent pSn-Fc protein that is partially degraded. Nevertheless, Coomassie Blue analysis of the same samples clearly indicated that the bulk of the protein was present in one specific band, which correlates with conformationally correct pSn-Fc protein.
###end p 51
###begin p 52
###xml 409 411 409 411 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 522 529 522 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g001">Fig. 1C</xref>
###xml 804 819 804 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Vibrio cholerae</italic>
###xml 1251 1255 1239 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Vanderheijden2">[36]</xref>
###xml 804 819 <span type="species:ncbi:666">Vibrio cholerae</span>
Wild type pSn undergoes processing in the endoplasmic reticulum (ER) and Golgi before being displayed at the cell membrane. During its passage through these compartments, the protein does not only obtain intramolecular disulfide bridges, but also N-linked glycans, which are often essential for proper protein folding. To check intracellular processing of the recombinant proteins, purified pSn4D-Fc and pSn4DRE-Fc proteins were treated with different glycosidases and analyzed via reducing SDS-PAGE and Western Blotting (Fig. 1C). Treatment of the proteins with N-glycosidase F, which removes all types of N-linked glycans, resulted in a clear shift in the protein size. Treatment with endoglycosidase H, which removes high mannose and some hybrid types of N-linked carbohydrates from glycoproteins, or Vibrio cholerae sialidase, removing sialic acids in a alpha2-3, alpha2-6 or alpha2-8 configuration, did not increase the electrophoretic mobility of the proteins. These results indicate that the soluble pSn proteins carry mainly complex type N-glycans capped with little or no sialic acids. The presence of these sugar moieties shows that the soluble sialoadhesins pass through the ER and Golgi for processing, as has been shown for wild type pSn [36].
###end p 52
###begin title 53
Functional characterization of pSn-Fc chimeras
###end title 53
###begin p 54
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Kelm1">[52]</xref>
###xml 346 358 346 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g002">Fig. 2A &amp; 2B</xref>
###xml 516 518 516 518 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 730 733 730 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">116</sup>
###xml 63 68 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Since the sialic acid-binding activity of pSn is essential for PRRSV binding, we first evaluated the sialic acid-binding capacity of the purified pSn4D-Fc protein. This was done via a solid phase red blood cell binding assay, a test routinely used to analyze the sialic acid-binding capacity of sialoadhesin-Fc and other siglec-Fc chimeras [52] (Fig. 2A & 2B). The pSn4D-Fc protein showed clear, sialic acid-dependent RBC binding, since removal of sialic acids from the RBC surface impeded the interaction. The pSn4DRE-Fc protein did not show RBC-binding activity. These results indicate that pSn4D-Fc has the capacity to bind sialic acids. As for full length pSn, the sialic acid-binding activity is critically dependent on the R116 residue within the N-terminal domain of pSn.
###end p 54
###begin title 55
###xml 81 86 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Evaluation of the functionality of pSn4D-Fc as a sialic acid-binding (A & B) and PRRSV-binding (C & D) protein.
###end title 55
###begin p 56
###xml 13 14 13 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 34 35 34 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 192 194 192 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 464 466 464 466 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 541 542 539 540 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 679 681 677 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 912 913 904 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 930 931 922 923 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1179 1180 1165 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 1524 1526 1498 1500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 234 239 <span type="species:ncbi:9606">human</span>
###xml 558 563 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 741 746 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 897 902 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 947 952 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1102 1107 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Qualitative (A) and quantitative (B) analysis of sialic acid-binding activity using a solid phase red blood cell binding assay. ELISA plates were coated with dilution series of pSn4D-Fc, pSn4DRE-Fc or mSiglecE-Fc protein, after which human RBCs were added and RBC binding was evaluated. pSn4D-Fc + RBCs (black square); pSn4D-Fc + sialidase-treated RBCs (white square); mSiglecE-Fc + RBCs (black diamond); mSiglecE-Fc + sialidase-treated RBCs (white diamond); pSn4DRE-Fc + RBCs (black circle). Values represent means+/-SEM of 3 experiments. (C) Evaluation of PRRSV-binding activity via immunoprecipitation experiments. Protein A beads were either coated with the pSn4D-Fc or pSn4DRE-Fc protein or not coated and incubated with MARC-145-grown PRRSV at 37degreesC to allow binding. The bound and unbound fractions were collected and subjected to non-reducing SDS-PAGE and Western Blot analysis using PRRSV N- and GP5-specific mAbs. (D) Evaluation of PRRSV-binding activity via infection-inhibition experiments. A 3-fold dilution series of pSn-Fc protein was mixed with a constant amount of MARC-145-grown PRRSV, incubated for 1 h at 37degreesC to allow binding and transferred to 105 alveolar macrophages. After 1 h of incubation at 37degreesC, pSn-Fc - virus mixtures were removed, fresh medium was added to the cells and cells were incubated for 9 h at 37degreesC, after which they were fixed. Infected cells were then visualized via nucleocapsid-specific immunoperoxidase staining and counted. pSn4D-Fc (white square); pSn4DRE-Fc (black square). Values represent means+/-SEM of 3 experiments.
###end p 56
###begin p 57
###xml 458 459 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 514 521 508 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g002">Fig. 2C</xref>
###xml 526 527 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 784 786 778 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 1142 1149 1136 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g002">Fig. 2D</xref>
###xml 1354 1356 1348 1350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 14 19 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 966 971 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1166 1171 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1628 1633 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1693 1698 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
To assess the PRRSV-binding capacity, pSn4D-Fc was coated on protein A beads and incubated with purified virus at 37degreesC to allow binding. The unbound fraction was then collected, beads were washed and the bound material was eluted from the beads. Samples of the bound and unbound fraction and samples of purified virus were then subjected to non-reducing SDS-PAGE and Western Blotting and analyzed for the presence of virus using mAbs recognizing the GP5 envelope glycoprotein and the nucleocapsid protein N (Fig. 2C). GP5 and N could clearly be detected in both the purified virus stock and the bound fraction, while little or no protein was found in the unbound fraction. These results show that pSn4D-Fc is able to efficiently bind the virus. When beads were coated with pSn4DRE-Fc or when uncoated beads were used, viral proteins were detected in the unbound fraction but not in the bound fraction. These findings show that the interaction of pSn4D-Fc with PRRSV is similar to the interaction between wild type pSn and the virus. To further substantiate this, we tested the soluble receptors for their infection-inhibition capacity (Fig. 2D). We found that PRRSV infection of alveolar macrophages could be partially blocked by pre-incubating the virus with pSn4D-Fc. This effect was dose-dependent and no such effect was obtained using the pSn4DRE-Fc protein, indicating that also here the sialic acid-binding functionality of pSn is crucial for the interaction. These data evidence that the soluble sialoadhesin pSn4D-Fc can compete with the wild type pSn on the macrophage surface for specific ligands present on the PRRSV virion surface and confirm the role of pSn as an important PRRSV receptor on macrophages.
###end p 57
###begin title 58
###xml 30 35 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Identification of pSn-binding PRRSV proteins and characterization of the pSn-ligand interaction
###end title 58
###begin p 59
###xml 589 596 583 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g003">Fig. 3A</xref>
###xml 601 602 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 606 607 600 601 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 620 621 614 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 727 728 721 722 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 775 776 769 770 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 783 784 777 778 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 873 874 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 942 944 936 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 1114 1115 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1160 1161 1154 1155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1272 1273 1266 1267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1364 1371 1358 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g003">Fig. 3B</xref>
###xml 1410 1411 1404 1405 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1433 1440 1427 1434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g003">Fig. 3C</xref>
###xml 34 39 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1227 1232 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
To identify viral ligands for the PRRSV receptor pSn, pSn4D-Fc was used in an immunoprecipitation reaction. PSn4D-Fc was coated on protein A beads and incubated with a lysate of purified virus at 37degreesC to allow binding. Subsequently, the unbound lysate fraction was collected, beads were washed and the bound material was eluted from the beads. Samples of the bound and unbound fraction and samples of the original virus lysate were subjected to non-reducing SDS-PAGE and Western Blotting and analyzed for the presence of specific viral envelope proteins using protein-specific mAbs (Fig. 3A). GP3, GP4 and the M/GP5 complex were all detected in the original virus lysate and in the unbound fraction. In addition, the M/GP5 complex was detected in the bound fraction. GP3 and GP4 were however not found in the bound fraction. These results indicate that the viral M/GP5 complex is able to bind to pSn4D-Fc. Control experiments with pSn4DRE-Fc pointed out that this protein does not interact with any of the viral proteins analyzed. This shows that the sialic acid-binding capacity of pSn is essential for M/GP5 binding and suggests that sialic acids on GP5 are involved in the interaction with pSn. Sialidase treatment of PRRSV, which removes sialic acids from the GP5 protein as indicated by an increased electrophoretic mobility of the protein on SDS-PAGE (Fig. 3B), indeed also resulted in loss of M/GP5 binding to pSn4D-Fc (Fig. 3C).
###end p 59
###begin title 60
###xml 74 79 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Identification of pSn-binding (glyco)protein(complexe)s of MARC-145-grown PRRSV and characterization of the pSn-ligand interaction.
###end title 60
###begin p 61
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 58 60 58 60 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 297 298 291 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 463 464 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 758 759 746 747 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 119 124 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 315 320 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 481 486 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 750 755 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
(A) Protein A beads were coated with the pSn4D-Fc or pSn4DRE-Fc proteins and incubated with a lysate of MARC-145-grown PRRSV at 37degreesC to allow binding. The bound and unbound fractions were collected and subjected to non-reducing SDS-PAGE and Western Blot analysis using virus-specific mAbs. (B) MARC-145-grown PRRSV was either treated with sialidase or control-treated and subjected to reducing SDS-PAGE and Western Blot analysis using virus-specific mAbs. (C) MARC-145-grown PRRSV was either treated with sialidase or control-treated, lysed and incubated with pSn4D-Fc-coated protein A beads at 37degreesC to allow binding. The bound and unbound fractions were collected and subjected to non-reducing SDS-PAGE and Western Blot analysis using a PRRSV GP5-specific mAb.
###end p 61
###begin p 62
###xml 125 126 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 482 488 482 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000730-g004">Fig. 4</xref>
###xml 528 529 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 766 768 766 768 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 807 808 807 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 815 816 815 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 475 480 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 571 576 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 890 895 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
The experiments described above clearly showed that sialic acids on the envelope glycoproteins are essential for the pSn-M/GP5 interaction. However, as the glycosylation machinery of MARC-145 cells and porcine macrophages differs, their glycome and the glycan array present on virus grown in these cells may differ substantially. As all experiments were performed with MARC-145-grown virus, immunoprecipitations were also performed using lysates of purified macrophage-grown PRRSV (Fig. 4). The results showed that also the M/GP5 glycoprotein complex of macrophage-grown PRRSV binds to the pSn4D-Fc protein. Binding was also critically dependent on the sialic acid-binding capacity of pSn, as no interaction was observed with the non-sialic acid-binding mutant pSn4DRE-Fc. No binding was observed for the GP3 and GP4 proteins. These results suggest that macrophage-grown and MARC-145-grown PRRSV interact with pSn in the same way.
###end p 62
###begin title 63
###xml 76 81 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Identification of pSn-binding (glyco)protein(complexe)s of macrophage-grown PRRSV.
###end title 63
###begin p 64
###xml 54 56 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RE</sub>
###xml 116 121 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Protein A beads were coated with the pSn4D-Fc or pSn4DRE-Fc protein and incubated with a lysate of macrophage-grown PRRSV at 37degreesC to allow binding. The bound and unbound fractions were collected and subjected to non-reducing SDS-PAGE and Western Blot analysis using virus-specific mAbs.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Duan3">[53]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Murtaugh1">[54]</xref>
###xml 449 453 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Vanderheijden2">[36]</xref>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Duan2">[44]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Duan4">[55]</xref>
###xml 1023 1027 1023 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Fort1">[56]</xref>
###xml 1028 1032 1028 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Bouma1">[59]</xref>
###xml 1349 1353 1349 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte3">[38]</xref>
###xml 1404 1408 1404 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte3">[38]</xref>
###xml 1409 1413 1409 1413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte4">[39]</xref>
###xml 1910 1911 1910 1911 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2167 2168 2167 2168 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2278 2279 2278 2279 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2349 2350 2349 2350 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2449 2450 2449 2450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2555 2556 2555 2556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 0 5 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 383 388 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 491 496 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 581 586 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 720 725 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 796 801 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 836 863 <span type="species:ncbi:11096">classical swine fever virus</span>
###xml 865 885 <span type="species:ncbi:85708">porcine circovirus 2</span>
###xml 1119 1124 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1182 1187 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1258 1263 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1508 1513 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1759 1764 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1877 1882 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 2505 2510 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 2581 2586 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
PRRSV has a very restricted tropism for subpopulations of differentiated cells of the monocyte/macrophage lineage. The virus infects macrophages in lungs and several lymphoid organs, while other cells such as circulating blood monocytes and peritoneal macrophages are refractory [53],[54]. This restricted cell tropism has been attributed to the restricted expression pattern of the PRRSV receptor pSn on these subsets of differentiated macrophages [36],[44],[55]. Since pSn is an essential PRRSV-binding and -internalization receptor on porcine macrophages, identification of the PRRSV glycoprotein ligands that mediate virus binding to this receptor is clearly of great importance, not only for basic understanding of PRRSV replication biology, but also for development of strategies to tackle PRRSV infection. For many viruses (e.g. classical swine fever virus, porcine circovirus 2), subunit vaccines comprising components involved in viral entry have proven very useful tools in the protection against viral infection [56]-[59]. A vaccine capable of inducing antibodies against the sialoadhesin-binding epitope of PRRSV should be capable of providing a good protection against PRRSV infection by neutralizing virus entry. Previously, the interaction of PRRSV with pSn was shown to be dependent on a functional sialic acid-binding domain on pSn [38] and on the presence of sialic acids on the virion [38],[39], but the sialic acid-carrying viral ligand was never identified. This study aimed to identify PRRSV glycoprotein ligands for the pSn receptor. For this purpose, a soluble pSn was constructed and characterized. This soluble receptor showed the same binding functionality as wild type pSn, as it showed sialic acid-binding activity and could bind PRRSV in a sialic acid-dependent manner. Via pull-down assays in which the soluble receptor was mixed with lysates of PRRSV, it was shown that the M/GP5 complex of the PRRS virus interacts with the pSn receptor. This interaction was clearly dependent on the sialic acid-binding capacity of pSn, as a non-sialic acid-binding mutant of the soluble pSn differing in only one amino acid was not able to bind M/GP5. Removal of sialic acids from the virus prior to the pull-down assay also blocked the interaction of the M/GP5 complex with pSn, evidencing the importance of sialic acids on the GP5 protein for interaction with the receptor. Clearly, the characteristics of the interaction of M/GP5 with pSn are identical to these of the interaction of PRRSV particles with pSn, suggesting that the M/GP5 complex indeed mediates PRRSV-particle binding to pSn.
###end p 66
###begin p 67
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte3">[38]</xref>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-VanGorp1">[40]</xref>
###xml 1022 1023 1022 1023 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1219 1220 1219 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1300 1308 1300 1308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1360 1367 1360 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1461 1468 1461 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 34 39 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 791 796 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 884 889 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 985 990 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
In this study, the interaction of PRRSV with the pSn receptor was initially studied using MARC-145-grown virus, as it is easy to obtain relatively high virus titers in these cells and it avoids the necessity of animal sacrifice. Moreover, MARC-145-grown virus can infect porcine alveolar macrophages and has been shown to interact efficiently with the pSn receptor [38],[40], indicating that MARC-145 cells provide correct glycosylation for the virus to interact with pSn. However, the glycome of the primary porcine macrophage, and hence of the virus grown therein, is most likely very different from the MARC-145 cell glycome. In the light of lectin-glycoprotein interaction, it was therefore imperative to evaluate the interaction of the viral glycoprotein(complexe)s of macrophage-grown PRRSV with the pSn receptor. Via pull-down experiments, in which lysates of macrophage-grown PRRSV were applied to immobilized recombinant sialoadhesins, it was found that also macrophage-grown PRRSV interacts with pSn via the M/GP5 glycoprotein complex. The interaction was also critically dependent on the sialic acid-binding capacity of pSn, indicating that the interaction of pSn with sialic acids is central to the pSn-M/GP5 interaction. While it should be kept in mind that primary macrophages cultured in vitro may also show different glycosylation than they do in vivo, it is clear that the interaction of pSn with macrophage-grown virus is more relevant to the in vivo situation than the interaction with MARC-145-grown virus.
###end p 67
###begin p 68
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte4">[39]</xref>
###xml 484 485 484 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 543 544 543 544 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Mardassi2">[25]</xref>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Dea2">[60]</xref>
###xml 733 737 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Meulenberg3">[61]</xref>
###xml 782 784 782 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 808 810 808 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">44</sup>
###xml 970 974 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wissink2">[62]</xref>
###xml 975 979 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Ansari1">[63]</xref>
###xml 1016 1018 1016 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 1117 1118 1117 1118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1120 1122 1120 1122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 1152 1154 1152 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 1275 1279 1275 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wissink2">[62]</xref>
###xml 1413 1417 1413 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte4">[39]</xref>
###xml 1497 1498 1497 1498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1572 1574 1572 1574 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 1576 1578 1576 1578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">44</sup>
###xml 1636 1638 1636 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 1640 1642 1640 1642 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">44</sup>
###xml 1706 1710 1706 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Plagemann1">[64]</xref>
###xml 1711 1715 1711 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Plagemann2">[66]</xref>
###xml 1752 1753 1752 1753 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1834 1835 1834 1835 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1893 1897 1893 1897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Ostrowski1">[65]</xref>
###xml 1898 1902 1898 1902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Pesch1">[70]</xref>
###xml 2053 2054 2053 2054 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2174 2175 2174 2175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2215 2219 2215 2219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Wissink1">[23]</xref>
###xml 2220 2224 2220 2224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Verheije1">[26]</xref>
###xml 2328 2329 2328 2329 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2446 2448 2446 2448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">46</sup>
###xml 2450 2452 2450 2452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">44</sup>
###xml 2466 2467 2466 2467 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 2636 2642 2636 2642 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2757 2761 2757 2761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Delputte5">[71]</xref>
###xml 20 25 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 561 566 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 956 961 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1700 1705 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 1878 1883 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Previous studies on PRRSV have shown that virus glycosylation is crucial for its infectivity towards macrophages. Treatment of the virus with N-glycosidase F to remove N-glycans has a negative impact on viral infectivity and removal of sialic acids from the virion surface using sialidase even results in a 10- to 20-fold reduction of the infectivity [39]. Considering the findings of the present study, these results suggest a central role of sialic acid-carrying N-glycans on the GP5 glycoprotein in the interaction with sialoadhesin. The GP5 protein of most PRRSV isolates contains two conserved N-glycosylation sites. One or more additional putative N-glycosylation sites can be present, depending on the virus isolate [25],[60],[61]. One of the conserved glycosylation sites, N46 in European isolates, N44 in American isolates, is particularly interesting in the light of the present study as it appears to be critical for the formation of infectious PRRSV virions [62],[63]. Wissink and coworkers showed that N46 is important for virus infectivity towards macrophages: the specific infectivity of recombinant GP5-N46Q mutant virus, in which the N46 glycosylation site was deleted, was reduced 10- to 20-fold when compared to the specific infectivity of wild type virus [62]. This correlates with the reduction in infectivity seen when virus is treated with sialidase to remove sialic acids from the surface [39]. Together, these data suggest that the critical sialic acid, necessary for M/GP5 binding to the pSn receptor, is present on the N-glycan appended to the N46/N44 amino acid. Another interesting observation is that the N46/N44 residue is part of the primary neutralization epitope of PRRSV [64]-[66]. While some other segments of the GP5 protein appear to be hypervariable, this epitope is located in an area of the GP5 ectodomain that is highly conserved among PRRSV isolates [65]-[70]. This suggests that this domain has a critical function in virus replication. It has been suggested to be crucial for the disulfide linkage between GP5 and M, as the cysteine residue involved in this linkage lies within the conserved area and since the linkage between GP5 and M is critical for virion formation [23],[26]. It is however also tempting to speculate that this critical function lies in the interaction of the GP5 glycoprotein with the sialoadhesin receptor, this via essential sialic acids present on the glycan appended to the N46/N44 residue of GP5. This could also explain why antibodies directed against this epitope appear to have a neutralizing effect on infection of macrophages. Previously, a study by Delputte et al. showed that neutralizing antibodies can indeed block attachment and internalization of the virus into macrophages [71].
###end p 68
###begin p 69
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Varki1">[72]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Crocker1">[73]</xref>
###xml 622 623 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 630 631 630 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 742 743 742 743 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Crocker2">[74]</xref>
###xml 1038 1042 1038 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Vanderheijden2">[36]</xref>
###xml 1101 1102 1101 1102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 1128 1132 1128 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000730-Meulenberg4">[75]</xref>
###xml 1059 1064 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Sialic acids are acidic monosaccharides often present at the termini of glycan chains on animal glycoconjugates [72]. Siglecs like sialoadhesin display a marked preference for specific types of sialic acids. However, also the linkage of the sialic acid to the subterminal sugar residue seems to influence the affinity of a siglec for a specific ligand. In addition, formation of high affinity interactions can depend on additional structural features of the glycoconjugate that carries the sialic acid [73]. These factors contribute to the specificity of a siglec for specific sialylated ligands and may explain why the GP3 and GP4 envelope proteins, although they carry sialic acids, do not seem to interact with sialoadhesin, while the M/GP5 glycoprotein complex shows a strong binding to this receptor. Furthermore, it is well known that physiologically relevant, high affinity lectin-glycan interactions strongly depend on the lectin and glycan valency [74]. As the pSn receptor is abundantly expressed at the macrophage cell surface [36] and as a single PRRSV virion carries a whole array of M/GP5 complexes on its surface [75], it can be expected that also the interaction between macrophage and virus depends on avidity rather than on simple affinity.
###end p 69
###begin p 70
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 126 127 126 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 253 254 253 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 50 55 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 447 452 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
In conclusion, we identified the M/GP5 complex of PRRSV as a ligand for the pSn receptor. Furthermore, we showed that the M/GP5-pSn interaction is critically dependent on the sialic acid-binding capacity of pSn as well as on sialic acids on the viral GP5 glycoprotein. The information and tools generated in this study can provide a theoretical and practical basis for the development and evaluation of a new generation of inactivated and subunit PRRSV vaccines.
###end p 70
###begin title 71
Supporting Information
###end title 71
###begin p 72
Immunofluorescence staining and confocal microscopy
###end p 72
###begin p 73
(0.04 MB PDF)
###end p 73
###begin p 74
Click here for additional data file.
###end p 74
###begin p 75
Fc- and pSn-specific ELISA assays
###end p 75
###begin p 76
(0.06 MB PDF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
The authors thank C. Boone, N. Dennequin, D. Helderweirt, T. Ysenbaert, L. Sys and C. Vanmaercke for excellent technical assistance and H. Favoreel for helpful comments and discussions. We also thank L. Bosseler, S. Costers and M. Vanhee for critical reading of the manuscript.
###end p 78
###begin title 79
References
###end title 79
###begin article-title 80
###xml 13 18 <span type="species:ncbi:9823">swine</span>
###xml 162 166 <span type="species:ncbi:9823">pigs</span>
Isolation of swine infertility and respiratory syndrome virus (isolate ATCC VR-2332) in North America and experimental reproduction of the disease in gnotobiotic pigs.
###end article-title 80
###begin article-title 81
###xml 8 13 <span type="species:ncbi:9823">swine</span>
###xml 59 73 <span type="species:ncbi:11049">Lelystad virus</span>
Mystery swine disease in The Netherlands: the isolation of Lelystad virus.
###end article-title 81
###begin article-title 82
Nidovirales: a new order comprising Coronaviridae and Arteriviridae.
###end article-title 82
###begin article-title 83
###xml 86 91 <span type="species:ncbi:9823">swine</span>
Assessment of the economic impact of porcine reproductive and respiratory syndrome on swine production in the United States.
###end article-title 83
###begin article-title 84
###xml 33 84 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China.
###end article-title 84
###begin article-title 85
###xml 19 24 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark.
###end article-title 85
###begin article-title 86
###xml 16 67 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Highly virulent porcine reproductive and respiratory syndrome virus emerged in China.
###end article-title 86
###begin article-title 87
Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine.
###end article-title 87
###begin article-title 88
###xml 20 71 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations.
###end article-title 88
###begin article-title 89
Effects of two commercial European modified-live vaccines against porcine reproductive and respiratory syndrome viruses in pregnant gilts.
###end article-title 89
###begin article-title 90
###xml 45 96 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.
###end article-title 90
###begin article-title 91
###xml 45 49 <span type="species:ncbi:9823">pigs</span>
###xml 96 147 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Strain specificity of the immune response of pigs following vaccination with various strains of porcine reproductive and respiratory syndrome virus.
###end article-title 91
###begin article-title 92
###xml 23 74 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 76 81 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 133 138 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 148 152 <span type="species:ncbi:9823">pigs</span>
The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs.
###end article-title 92
###begin article-title 93
###xml 143 148 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Failure of an inactivated vaccine against porcine reproductive and respiratory syndrome to protect gilts against a heterologous challenge with PRRSV.
###end article-title 93
###begin article-title 94
###xml 41 92 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 94 99 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge.
###end article-title 94
###begin article-title 95
###xml 20 25 <span type="species:ncbi:9823">swine</span>
Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332).
###end article-title 95
###begin article-title 96
###xml 53 104 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Ultrastructural characteristics and morphogenesis of porcine reproductive and respiratory syndrome virus propagated in the highly permissive MARC-145 cell clone.
###end article-title 96
###begin article-title 97
###xml 0 51 <span type="species:ncbi:28344">Porcine reproductive and respiratory syndrome virus</span>
Porcine reproductive and respiratory syndrome virus: morphological, biochemical and serological characteristics of Quebec isolates associated with acute and chronic outbreaks of porcine reproductive and respiratory syndrome.
###end article-title 97
###begin article-title 98
###xml 0 14 <span type="species:ncbi:11049">Lelystad virus</span>
###xml 113 116 <span type="species:ncbi:11048?0.5860927152317881|species:ncbi:36363?0.026490066225165563">LDV</span>
###xml 121 124 <span type="species:ncbi:11047?0.9055555555555556">EAV</span>
Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (PEARS), is related to LDV and EAV.
###end article-title 98
###begin article-title 99
###xml 0 14 <span type="species:ncbi:11049">Lelystad virus</span>
###xml 101 106 <span type="species:ncbi:9823">swine</span>
Lelystad virus, the cause of porcine epidemic abortion and respiratory syndrome: a review of mystery swine disease research at Lelystad.
###end article-title 99
###begin article-title 100
Arteriviruses.
###end article-title 100
###begin article-title 101
###xml 37 42 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
GP3 is a structural component of the PRRSV type II (US) virion.
###end article-title 101
###begin article-title 102
###xml 72 123 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Envelope protein requirements for the assembly of infectious virions of porcine reproductive and respiratory syndrome virus.
###end article-title 102
###begin article-title 103
###xml 88 139 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
A nonstructural and antigenic glycoprotein is encoded by ORF3 of the IAF-Klop strain of porcine reproductive and respiratory syndrome virus.
###end article-title 103
###begin article-title 104
###xml 89 140 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Intracellular synthesis, processing, and transport of proteins encoded by ORFs 5 to 7 of porcine reproductive and respiratory syndrome virus.
###end article-title 104
###begin article-title 105
###xml 27 78 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Genetic engineering of the porcine reproductive and respiratory syndrome virus: exploration of avenues towards a vaccine. Dissertation, Utrecht University, The Netherlands
###end article-title 105
###begin article-title 106
###xml 69 83 <span type="species:ncbi:11049">Lelystad virus</span>
Identification and characterization of a sixth structural protein of Lelystad virus: the glycoprotein GP2 encoded by ORF2 is incorporated in virus particles.
###end article-title 106
###begin article-title 107
###xml 65 79 <span type="species:ncbi:11049">Lelystad virus</span>
Proteins encoded by open reading frames 3 and 4 of the genome of Lelystad virus (Arteriviridae) are structural proteins of the virion.
###end article-title 107
###begin article-title 108
###xml 31 82 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
A 10-kDa structural protein of porcine reproductive and respiratory syndrome virus encoded by ORF2b.
###end article-title 108
###begin article-title 109
###xml 97 101 <span type="species:ncbi:9823">pigs</span>
###xml 153 204 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 206 211 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Virus quantification and identification of cellular targets in the lungs and lymphoid tissues of pigs at different time intervals after inoculation with porcine reproductive and respiratory syndrome virus (PRRSV).
###end article-title 109
###begin article-title 110
###xml 22 73 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Detection of European porcine reproductive and respiratory syndrome virus in porcine alveolar macrophages by two-colour immunofluorescence and in-situ hybridization-immunohistochemistry double labelling.
###end article-title 110
###begin article-title 111
Enhanced replication of porcine reproductive and respiratory syndrome (PRRS) virus in a homogeneous subpopulation of MA-104 cell line.
###end article-title 111
###begin article-title 112
###xml 12 63 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Analysis of porcine reproductive and respiratory syndrome virus attachment and internalization: distinctive roles for heparan sulphate and sialoadhesin.
###end article-title 112
###begin article-title 113
###xml 51 102 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Involvement of the matrix protein in attachment of porcine reproductive and respiratory syndrome virus to a heparinlike receptor on porcine alveolar macrophages.
###end article-title 113
###begin article-title 114
###xml 35 86 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Effects of heparin on the entry of porcine reproductive and respiratory syndrome virus into alveolar macrophages.
###end article-title 114
###begin article-title 115
###xml 40 91 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Involvement of sialoadhesin in entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages.
###end article-title 115
###begin article-title 116
###xml 9 60 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Entry of porcine reproductive and respiratory syndrome virus into porcine alveolar macrophages via receptor-mediated endocytosis.
###end article-title 116
###begin article-title 117
Porcine arterivirus attachment to the macrophage-specific receptor sialoadhesin is dependent on the sialic acid-binding activity of the N-terminal immunoglobulin domain of sialoadhesin.
###end article-title 117
###begin article-title 118
Porcine arterivirus infection of alveolar macrophages is mediated by sialic acid on the virus.
###end article-title 118
###begin article-title 119
###xml 55 106 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Sialoadhesin and CD163 join forces during entry of the porcine reproductive and respiratory syndrome virus.
###end article-title 119
###begin article-title 120
CD163 expression confers susceptibility to porcine reproductive and respiratory syndrome viruses.
###end article-title 120
###begin article-title 121
###xml 0 51 <span type="species:ncbi:28344">Porcine reproductive and respiratory syndrome virus</span>
Porcine reproductive and respiratory syndrome virus enters cells through a low pH-dependent endocytic pathway.
###end article-title 121
###begin article-title 122
###xml 28 79 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Involvement of proteases in porcine reproductive and respiratory syndrome virus uncoating upon internalization in primary macrophages.
###end article-title 122
###begin article-title 123
###xml 42 93 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Identification of a putative receptor for porcine reproductive and respiratory syndrome virus on porcine alveolar macrophages.
###end article-title 123
###begin article-title 124
###xml 24 29 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 100 103 <span type="species:ncbi:9823">pig</span>
Strategies exhibited by PRRSV allowing evasion of immune detection and/or clearance in the infected pig. Dissertation, Ghent University, Belgium.
###end article-title 124
###begin article-title 125
###xml 0 51 <span type="species:ncbi:28344">Porcine reproductive and respiratory syndrome virus</span>
###xml 53 58 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
###xml 146 157 <span type="species:ncbi:280756">S. isolates</span>
Porcine reproductive and respiratory syndrome virus (PRRSV): monoclonal antibodies detect common epitopes on two viral proteins of European and U.S. isolates.
###end article-title 125
###begin article-title 126
###xml 63 81 <span type="species:ncbi:10345">pseudorabies virus</span>
Effect of specific antibodies on the cell-associated spread of pseudorabies virus in monolayers of different cell types.
###end article-title 126
###begin article-title 127
###xml 28 53 <span type="species:ncbi:85708">porcine circovirus type 2</span>
Antigenic differences among porcine circovirus type 2 strains, as demonstrated by the use of monoclonal antibodies.
###end article-title 127
###begin article-title 128
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations.
###end article-title 128
###begin article-title 129
###xml 100 105 <span type="species:ncbi:9606">human</span>
Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes.
###end article-title 129
###begin article-title 130
###xml 4 10 <span type="species:ncbi:10090">murine</span>
The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils.
###end article-title 130
###begin article-title 131
Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily.
###end article-title 131
###begin article-title 132
###xml 114 165 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 167 172 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Effects of origin and state of differentiation and activation of monocytes/macrophages on their susceptibility to porcine reproductive and respiratory syndrome virus (PRRSV).
###end article-title 132
###begin article-title 133
###xml 27 32 <span type="species:ncbi:9823">swine</span>
###xml 36 87 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Immunological responses of swine to porcine reproductive and respiratory syndrome virus infection.
###end article-title 133
###begin article-title 134
###xml 0 51 <span type="species:ncbi:28344">Porcine reproductive and respiratory syndrome virus</span>
Porcine reproductive and respiratory syndrome virus infection of alveolar macrophages can be blocked by monoclonal antibodies against cell surface antigens.
###end article-title 134
###begin article-title 135
###xml 0 25 <span type="species:ncbi:85708">Porcine circovirus type 2</span>
###xml 27 31 <span type="species:ncbi:85708">PCV2</span>
###xml 61 65 <span type="species:ncbi:9823">pigs</span>
###xml 91 95 <span type="species:ncbi:85708">PCV2</span>
Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins.
###end article-title 135
###begin article-title 136
###xml 14 34 <span type="species:ncbi:85708">porcine circovirus 2</span>
###xml 36 40 <span type="species:ncbi:85708">PCV2</span>
###xml 164 168 <span type="species:ncbi:85708">PCV2</span>
One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
###end article-title 136
###begin article-title 137
###xml 85 89 <span type="species:ncbi:85708">PCV2</span>
Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.
###end article-title 137
###begin article-title 138
###xml 72 99 <span type="species:ncbi:11096">classical swine fever virus</span>
Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus.
###end article-title 138
###begin article-title 139
Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates.
###end article-title 139
###begin article-title 140
###xml 55 69 <span type="species:ncbi:11049">Lelystad virus</span>
Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus.
###end article-title 140
###begin article-title 141
###xml 44 95 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Significance of the oligosaccharides of the porcine reproductive and respiratory syndrome virus glycoproteins GP2a and GP5 for infectious virus production.
###end article-title 141
###begin article-title 142
###xml 39 90 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Influence of N-linked glycosylation of porcine reproductive and respiratory syndrome virus GP5 on virus infectivity, antigenicity, and ability to induce neutralizing antibodies.
###end article-title 142
###begin article-title 143
###xml 38 89 <span type="species:ncbi:28344">porcine respiratory and reproductive syndrome virus</span>
The primary neutralization epitope of porcine respiratory and reproductive syndrome virus strain VR-2332 is located in the middle of the GP5 ectodomain.
###end article-title 143
###begin article-title 144
###xml 67 118 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Identification of neutralizing and nonneutralizing epitopes in the porcine reproductive and respiratory syndrome virus GP5 ectodomain.
###end article-title 144
###begin article-title 145
###xml 69 120 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus.
###end article-title 145
###begin article-title 146
###xml 26 77 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 79 84 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
Molecular epidemiology of porcine reproductive and respiratory syndrome virus (PRRSV) in Quebec.
###end article-title 146
###begin article-title 147
###xml 13 64 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 95 99 <span type="species:ncbi:9823">pigs</span>
Evolution of porcine reproductive and respiratory syndrome virus during sequential passages in pigs.
###end article-title 147
###begin article-title 148
###xml 50 101 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Identification of radically different variants of porcine reproductive and respiratory syndrome virus in Eastern Europe: towards a common ancestor for European and American viruses.
###end article-title 148
###begin article-title 149
###xml 52 103 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
###xml 105 110 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
New insights into the genetic diversity of European porcine reproductive and respiratory syndrome virus (PRRSV).
###end article-title 149
###begin article-title 150
###xml 84 135 <span type="species:ncbi:28344">porcine reproductive and respiratory syndrome virus</span>
Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages.
###end article-title 150
###begin article-title 151
Sialic acids as ligands in recognition phenomena.
###end article-title 151
###begin article-title 152
Siglecs and their roles in the immune system.
###end article-title 152
###begin article-title 153
Siglecs as positive and negative regulators of the immune system.
###end article-title 153
###begin article-title 154
###xml 0 5 <span type="species:ncbi:28344?0.9455645161290323">PRRSV</span>
PRRSV, the virus.
###end article-title 154
###begin p 155
The authors have declared that no competing interests exist.
###end p 155
###begin p 156
This research was funded by the Flemish Institute for the Promotion of Innovation by Science and Technology (I.W.T.-Flanders; SB 61491 & 63491; ), FWO-Vlaanderen (A 4/5 EP 1.2.595.09; ), the European Molecular Biology Organization (EMBO; ASTF 132.00-05; ) and the National Pork Board (NPB Project #05-191; ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 156

